The Short Answer Educational content only, not medical advice. No test described here diagnoses concussion on its own, and concussion diagnosis remains clinical. The advanced imaging methods covered in this series are research tools that detect group-level differences and are not validated to diagnose or exclude concussion in an individual person. Be cautious about clinics selling scans or brain maps as diagnostic. Discuss any assessment with a concussion-experienced clinician who can interpret it alongside your history and examination. Magnetic resonance spectroscopy measures the concentration of specific chemical compounds in a defined volume of brain tissue rather than producing an anatomical image, using the fact that each compound resonates at a slightly different frequency. The most important for concussion is N-acetylaspartate, found almost exclusively in neurons and used as a marker of neuronal integrity and mitochondrial function. A systematic review and meta-analysis examined spectroscopy following mild traumatic brain injury and its potential to detect post-traumatic neurodegeneration (Eisele et al., 2020). It remains a research method rather than a clinical diagnostic. It measures chemical concentrations, not anatomy. N-acetylaspartate serves as a marker of neuronal integrity. A systematic review and meta-analysis has examined its potential in mild injury. What the Spectrum Contains The output is a graph of signal intensity against frequency, with peaks corresponding to different compounds. N-acetylaspartate produces the largest peak in healthy brain and reflects neuronal and axonal integrity, decreasing when neurons are damaged or mitochondrial function is impaired. Choline reflects membrane turnover and increases with membrane breakdown or repair. Creatine reflects energy metabolism and is relatively stable, so it is often used as a reference denominator. Myo-inositol is a glial marker. Lactate appears when metabolism shifts toward anaerobic pathways and is normally near-undetectable, making its presence notable. Why It Matches Concussion Pathophysiology Concussion is described as a neurometabolic cascade rather than a structural injury. The impact triggers indiscriminate release of neurotransmitters and massive ion flux, and restoring ionic balance consumes large amounts of energy at exactly the time cerebral blood flow is reduced. The result is an energy crisis with impaired mitochondrial function, which corresponds to the symptomatic period. Spectroscopy is the only widely available method measuring this metabolic state directly rather than inferring it, which is why the reduced N-acetylaspartate finding after concussion has attracted sustained interest. What Studies Report Reduced N-acetylaspartate, often expressed as a ratio to creatine, is the most consistently described finding after concussion, with recovery of the ratio over subsequent weeks in many studies. This time course is interesting because some work suggests metabolic recovery lags symptom resolution, which has implications for return-to-play timing and for vulnerability to repeat injury during the recovery window. The systematic review and meta-analysis of spectroscopy after mild traumatic brain injury assessed the strength of these findings and their potential to indicate post-traumatic neurodegeneration (Eisele et al., 2020). The Technical Limitations Spectroscopy has practical constraints limiting clinical translation. Spatial resolution is poor, since adequate signal requires a relatively large voxel, typically a cubic centimeter or more, so the measurement averages across tissue types and misses focal changes. Voxel placement is operator-dependent and hard to reproduce exactly between sessions, which is a serious problem for serial measurement. Acquisition is slow and sensitive to motion and to magnetic field inhomogeneity, particularly near air-tissue boundaries. Absolute quantification is difficult, so most studies report ratios, which conflate changes in the numerator and the denominator. Current Standing Spectroscopy has established clinical uses in tumor characterization, some metabolic disorders, and certain infections, so the technique is available on many scanners. Its concussion application lacks standardized voxel placement, normative data by age and sex, and validated individual thresholds, which is the recurring barrier across advanced methods (Maas et al., 2022). Its main contribution has been supporting the neurometabolic model of concussion and the idea that physiological recovery may outlast symptoms, which informs conservative return-to-play thinking reflected in consensus guidance (Patricios et al., 2023). Assessment identifies what is driving symptoms. Cervical and vestibular contributors are among the most commonly found and the most treatable. Start your 3-day free trial for joint-specific mobility programming addressing the neck side of those findings. Supporting Mobility Routine JME 14 Chin tucks reduce the upper cervical tension driving cervicogenic headache, one of the most common findings on post-concussion assessment. Ten repetitions with 5-second holds. JME 1 Cervical rotation restores segmental mobility, which is directly relevant where assessment identifies a cervical contribution to dizziness. Ten repetitions per direction. JME 15 Cervical lateral flexion addresses side-bending restriction sustaining neck tension and headache. Ten repetitions per side. JME 16 Cervical flexion and extension restore sagittal mobility restricted by suboccipital guarding after impact. Eight slow repetitions. JME 2 Cervical retraction reinforces a neutral head position, reducing the postural strain that worsens symptoms during screen-based testing. Ten repetitions per set. JME 150 Thoracic rotation restores mid-back motion, which reduces compensatory load on the cervical spine. Eight repetitions per direction. JME 227 Overhead reach opens the thoracic spine and rib cage, supporting the breathing mechanics behind nervous system regulation. Ten repetitions with controlled tempo. JME 155 Diaphragmatic breathing lowers sympathetic drive, which reduces the symptom load that degrades performance on any cognitive assessment. Ten slow breaths, several times daily. Start your 3-day free trial for joint-specific mobility programming addressing the cervical contributors assessment identifies. Common Mistakes Expecting an image, when the output is a chemical spectrum Interpreting ratios without considering changes in the denominator Comparing serial scans with different voxel placement Assuming poor spatial resolution captures focal changes Treating research findings as individual diagnostic evidence Pursuing spectroscopy before clinical assessment of symptom drivers Reading normal results as excluding ongoing problems Progression Standard imaging serves emergency exclusion. Clinical assessment of vestibular, ocular, cervical, sleep, and mood contributors follows, since these identify what is treatable. Treat spectroscopy as a research method rather than a clinical step. Where its underlying finding matters practically, the implication is conservative return-to-play timing, which consensus guidance already builds in through graded progression. Reassess persistent symptoms clinically rather than pursuing metabolic imaging. What does MRS measure? The concentration of specific chemical compounds in a defined tissue volume, displayed as a spectrum of peaks. Key compounds include N-acetylaspartate for neuronal integrity, choline for membrane turnover, creatine for energy metabolism, myo-inositol as a glial marker, and lactate for anaerobic metabolism. Why is N-acetylaspartate important after concussion? It is found almost exclusively in neurons and reflects neuronal integrity and mitochondrial function, so it decreases when neurons are damaged or energy metabolism is impaired. Reduced levels are the most consistently reported spectroscopy finding after concussion. Does metabolic recovery track symptom recovery? Some research suggests metabolic recovery lags symptom resolution, which has implications for return-to-play timing and vulnerability to repeat injury during the recovery window. This finding supports the conservative graded return approach in consensus guidance. Why is MRS not used clinically for concussion? It lacks standardized voxel placement, normative data by age and sex, and validated individual thresholds. Poor spatial resolution, operator-dependent voxel placement complicating serial comparison, and reliance on ratios rather than absolute values all limit individual interpretation. Is MRS used clinically at all? Yes, for tumor characterization, some metabolic disorders, and certain infections, so the technique is mature and available on many scanners. Its concussion application is research rather than diagnostic. How These Tools Fit Together Concussion diagnosis is clinical. It rests on the injury mechanism, the symptoms, and the examination, and international consensus guidance is explicit that no single test establishes or excludes the diagnosis (Patricios et al., 2023). Everything described in this series sits in a supporting role. Sideline and clinic tools such as SCAT6, VOMS, and King-Devick add structure and reproducibility to the clinical assessment. Computerized cognitive batteries quantify one specific domain. Advanced imaging methods detect group-level differences in research populations and are not validated for individual diagnosis (Maas et al., 2022). Confusing these roles is the most common error patients and clinicians make. What Assessment Is Actually For Confirming a clinical picture already suspected from history and examination Identifying which subtype is driving symptoms: vestibular, ocular, cervical, mood, sleep, or migraine Tracking change over time against the person's own earlier results Supporting return-to-play and return-to-work decisions with objective data Ruling out structural injury needing emergency treatment, which is what standard CT does Directing treatment toward the specific system involved Documenting recovery for insurance, legal, or occupational purposes Why Advanced Imaging Is Not Diagnostic Yet The barrier is not that these methods detect nothing. Diffusion imaging, functional MRI, magnetoencephalography, spectroscopy, and perfusion imaging all show reproducible group differences between concussed and control populations. The barrier is the gap between a group difference and an individual diagnosis. Concussion effects are small relative to normal human variation, findings differ in direction between studies and time points, most research lacks pre-injury baselines, acquisition and analysis methods vary between centers, and few studies report the sensitivity and specificity needed to classify one person (Lindsey et al., 2023, and Mayer et al., 2015). A test cannot be clinically diagnostic until it performs reliably on a single scan against a validated normative reference, and that threshold has not been met. Questions Worth Asking About Any Test Several questions separate useful assessment from expensive noise. Does the result change treatment, or only produce a label. Is there a baseline or normative comparison appropriate to your age, sex, and background. What are the sensitivity and specificity for individual diagnosis, and does the provider quote them. Would a concussion-experienced clinician interpret this alongside examination findings, or is it delivered as a standalone report. Is the test being sold directly to patients outside standard clinical pathways. Persistent symptoms usually reflect treatable vestibular, cervical, visual, sleep, or mood problems, and identifying those through clinical assessment changes management in a way most advanced imaging currently does not (Silverberg et al., 2020). References Patricios, J. S., Schneider, K. J., Dvorak, J., et al. (2023). Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport, Amsterdam, October 2022. British Journal of Sports Medicine, 57(11), 695-711. PubMed Echemendia, R. J., Brett, B. L., Broglio, S., et al. (2023). Sport Concussion Assessment Tool 6 (SCAT6). British Journal of Sports Medicine, 57(11), 622-631. PubMed Mucha, A., Collins, M. W., Elbin, R. J., et al. (2014). A brief Vestibular/Ocular Motor Screening (VOMS) assessment to evaluate concussions: preliminary findings. American Journal of Sports Medicine, 42(10), 2479-2486. PubMed Krause, D. A., Hollman, J. H., Breuer, L. T., et al. (2022). Validity indices of the King-Devick concussion test in hockey players. Clinical Journal of Sport Medicine, 32(3), e313-e315. PubMed Farnsworth, J. L., Dargo, L., Ragan, B. G., et al. (2017). Reliability of computerized neurocognitive tests for concussion assessment: a meta-analysis. Journal of Athletic Training, 52(9), 826-833. PubMed Wilmoth, K., Brett, B. L., Emmert, N. A., et al. (2023). Psychometric properties of computerized cognitive tools and standard neuropsychological tests used to assess sport concussion: a systematic review. Neuropsychology Review, 33(4), 675-692. PubMed Dretsch, M., Parish, R., Kelly, M., et al. (2015). Eight-day temporal stability of the Automated Neuropsychological Assessment Metric (ANAM) in a deployment environment. Applied Neuropsychology: Adult, 22(4), 304-310. PubMed Tenney, J. R., Gloss, D., Arya, R., et al. (2021). Practice guideline: use of quantitative EEG for the diagnosis of mild traumatic brain injury. Report of the Guideline Committee of the American Clinical Neurophysiology Society. Journal of Clinical Neurophysiology, 38(4), 287-292. PubMed Lindsey, H. M., Hodges, C. B., Greer, K. M., et al. (2023). Diffusion-weighted imaging in mild traumatic brain injury: a systematic review of the literature. Neuropsychology Review, 33(1), 42-121. PubMed Mayer, A. R., Bellgowan, P. S., & Hanlon, F. M. (2015). Functional magnetic resonance imaging of mild traumatic brain injury. Neuroscience and Biobehavioral Reviews, 49, 8-18. PubMed Huang, M., Lewine, J. D., & Lee, R. R. (2020). Magnetoencephalography for mild traumatic brain injury and posttraumatic stress disorder. Neuroimaging Clinics of North America, 30(2), 175-192. PubMed Hageman, G., Hof, J., Nihom, J., et al. (2022). Susceptibility-weighted MRI and microbleeds in mild traumatic brain injury: prediction of posttraumatic complaints? European Neurology, 85(3), 177-185. PubMed Eisele, A., Hill-Strathy, M., Michels, L., et al. (2020). Magnetic resonance spectroscopy following mild traumatic brain injury: a systematic review and meta-analysis on the potential to detect posttraumatic neurodegeneration. Neurodegenerative Diseases, 20(1), 2-11. PubMed Hamer, J., Churchill, N. W., Hutchison, M. G., et al. (2020). Sex differences in cerebral blood flow associated with a history of concussion. Journal of Neurotrauma, 37(10), 1197-1203. PubMed Alosco, M. L., Mariani, M. L., Adler, C. H., et al. (2021). Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project. Alzheimer's Research and Therapy, 13(1), 136. PubMed Maas, A. I. R., Menon, D. K., Manley, G. T., et al. (2022). Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurology, 21(11), 1004-1060. PubMed Silverberg, N. D., Iaccarino, M. A., Panenka, W. J., et al. (2020). Management of concussion and mild traumatic brain injury: a synthesis of practice guidelines. Archives of Physical Medicine and Rehabilitation, 101(2), 382-393. PubMed